Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $1.49, but opened at $1.56. Akso Health Group shares last traded at $1.54, with a volume of 228 shares trading hands.
Analyst Ratings Changes
Several research analysts recently commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Akso Health Group in a report on Monday, April 20th. Wall Street Zen raised shares of Akso Health Group to a “sell” rating in a report on Saturday, May 2nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Akso Health Group presently has a consensus rating of “Sell”.
Get Our Latest Analysis on Akso Health Group
Akso Health Group Stock Up 3.4%
Institutional Investors Weigh In On Akso Health Group
A hedge fund recently bought a new position in Akso Health Group stock. SmartHarvest Portfolios LLC acquired a new stake in Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 16,748 shares of the company’s stock, valued at approximately $27,000. 1.21% of the stock is currently owned by institutional investors and hedge funds.
About Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Featured Articles
- Five stocks we like better than Akso Health Group
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
